THOMAS R II STAAB

CIK 1230708 · Chief Financial Officer · last filed 2026-05-13

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.22M

Companies

4

Total Filings

104

Lifetime Open-Market Net

-$2.31M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TENX Chief Financial Officer 10,000 $11.48 $114.8K $0 1 2026-05-13
LNSR Chief Financial Officer 174,609 $5.82 $1.02M $8.7K 13 2026-05-08
BCRX Senior Vice President and CFO 125,176 $8.70 $1.09M -$2.32M 71 2020-02-25
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted EVP, CFO & Treasurer 0 $0 19 2011-05-16

Recent Filings · Page 2 of 11

104 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-12-07 LNSR Buy (P) +2,752 $8.7K EDGAR
2022-01-13 LNSR Grant (A) +15,000 $0 EDGAR
2021-04-14 LNSR Grant (A) $0 EDGAR
2020-12-10 LNSR Grant (A) +19,276 $0 EDGAR
2020-02-25 BCRX Grant (A) $0 EDGAR
2020-02-19 BCRX Grant (A) $0 EDGAR
2019-12-26 BCRX Grant (A) $0 EDGAR
2019-12-19 BCRX Grant (A) $0 EDGAR
2019-05-20 BCRX Mixed −5,000 -$67.8K EDGAR
2019-05-16 BCRX Mixed −2,500 -$78.6K EDGAR
Showing 1120 of 104
Page 2 of 11
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.